CEO

           Mahmoud Khattab Recap

Mahmoud Khattab is the CEO of precision MD, a company that develops interactive medical devices for healthcare professionals. He’s an expert in high-frequency sound waves and a professor at the University of Pennsylvania. Learn more information about Mahmoud Khattab

Today, his work is focused on developing a device that can be used to treat kidney failure, and he is currently preparing for one of his most extensive tests with the device.

He has an impressive background, including multiple MIT and Harvard University degrees. He also worked as an engineer at both Intel and Apple for several years. He holds over a dozen computer science and engineering patents, but he is just as well known for his philanthropy as he is for his academic achievements.

His work leading up to this study: Khattab’s previous research focused on how high-frequency sound waves could be used to treat cancer patients without damaging healthy tissue or organs nearby. Khattab could treat tumors without destroying surrounding organs and tissues using pressure waves or high-frequency sound waves.

He did this by focusing an acoustic beam directly on the tumor. He used a device similar to an ultrasound scanner, but instead of using it as we would typically see it, he positioned the device more closely to the patient.

Using this unique positioning allowed him to direct a focused acoustic wave at the tumor while minimizing any damage that could have been caused by tissue vibrations elsewhere. The sound beam worked as it would in any other treatment: once it came into contact with the tumor, the cells of that area became too hot and started dying off rapidly.

Khattab’s idea is to use this same sort of device to help treat kidney failure. He has developed a new device that can be made smaller while still allowing the user to precisely target the small kidney area that needs treatment. It should allow doctors to purge blood cells directly from the kidneys and keep them functioning normally.

While he has been successful in treating other cancerous tumors, two concerns prevented him from being able to be as successful with kidney failure: first, his previous device would destroy nearby healthy tissue, and second, it was too big and cumbersome to maneuver around in a patient’s body easily.